Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1368 ARTÍCULOS , VIENDO DEL 361 AL 375

Understanding Frontotemporal Disease Progression and Management Strategies

Mulkey M.

Nurs Clin North Am. 2019 Sep;54(3):437-448. doi: 10.1016/j.cnur.2019.04.011. Epub 2019 Jun 8.

[Anti-tau therapies-what can be expected?]

Fließbach K, McCormick C, Kaulen B, Schneider A.

Nervenarzt. 2019 Sep;90(9):891-897. doi: 10.1007/s00115-019-0758-7.

Commentary for Sequential Therapy Based on Evolvement of Patterns: A New Model for Treatment of Alzheimer's Disease

Wilcock G, Neary D.

Chin J Integr Med. 2019 Aug;25(8):563-564. doi: 10.1007/s11655-019-3068-9.

Therapeutic Approaches to Alzheimer's Type of Dementia: A Focus on FGF21 Mediated Neuroprotection

Taliyan R, Chandran SK, Kakoty V.

Curr Pharm Des. 2019;25(23):2555-2568. doi: 10.2174/1381612825666190716101411.

Anti-Aβ Antibodies and Cerebral Amyloid Angiopathy Complications

Chantran Y, Capron J, Alamowitch S, Aucouturier P.

Front Immunol. 2019 Jul 4;10:1534. doi: 10.3389/fimmu.2019.01534. eCollection 2019.

Targeting apolipoprotein E for treating Alzheimer's disease

Bales KR, Paul SM.

Neurosci Lett. 2019 Sep 14;709:134366. doi: 10.1016/j.neulet.2019.134366. Epub 2019 Jul 20.

How relevant are social costs in economic evaluations? The case of Alzheimer's disease

Peña-Longobardo LM, Rodríguez-Sánchez B, Oliva-Moreno J, Aranda-Reneo I, López-Bastida J.

Eur J Health Econ. 2019 Nov;20(8):1207-1236. doi: 10.1007/s10198-019-01087-6. Epub 2019 Jul 24.

Stoichiometry of Heavy Metal Binding to Peptides Involved in Alzheimer's Disease: Mass Spectrometric Evidence

Jureschi M, Lupaescu AV, Ion L, Petre BA, Drochioiu G.

Adv Exp Med Biol. 2019;1140:401-415. doi: 10.1007/978-3-030-15950-4_23.

Diverse and dynamic DNA modifications in brain and diseases

Armstrong MJ, Jin Y, Allen EG, Jin P.

Hum Mol Genet. 2019 Nov 21;28(R2):R241-R253. doi: 10.1093/hmg/ddz179.

The effects of insulin and insulin-like growth factor I on amyloid precursor protein phosphorylation in in vitro and in vivo models of Alzheimer's disease

Kim B, Elzinga SE, Henn RE, McGinley LM, Feldman EL.

Neurobiol Dis. 2019 Dec;132:104541. doi: 10.1016/j.nbd.2019.104541. Epub 2019 Jul 23.

Digging Deeper Into Delusion Circuitry in Alzheimer's Disease

Prasad KM.

Am J Geriatr Psychiatry. 2019 Oct;27(10):1069-1071. doi: 10.1016/j.jagp.2019.06.016. Epub 2019 Jul 3.

Promoter DNA hypermethylation - Implications for Alzheimer's disease

Liu Y, Wang M, Marcora EM, Zhang B, Goate AM.

Neurosci Lett. 2019 Oct 15;711:134403. doi: 10.1016/j.neulet.2019.134403. Epub 2019 Jul 24.

Time for the systems-level integration of aging: Resilience enhancing strategies to prevent Alzheimer's disease

Hampel H, Lista S, Neri C, Vergallo A.

Prog Neurobiol. 2019 Oct;181:101662. doi: 10.1016/j.pneurobio.2019.101662. Epub 2019 Jul 25.

Triazole derivatives as inhibitors of Alzheimer's disease: Current developments and structure-activity relationships

Xu M, Peng Y, Zhu L, Wang S, Ji J, Rakesh KP.

Eur J Med Chem. 2019 Oct 15;180:656-672. doi: 10.1016/j.ejmech.2019.07.059. Epub 2019 Jul 22.

The clinical and economic burden among caregivers of patients with Alzheimer's disease in Canada

Szabo S, Lakzadeh P, Cline S, Palma Dos Reis R, Petrella R.

Int J Geriatr Psychiatry. 2019 Nov;34(11):1677-1688. doi: 10.1002/gps.5182. Epub 2019 Aug 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias